Efficacy of lurasidone in the treatment of schizophrenia with prominent negative symptoms: a post-hoc analysis of five short-term trials

被引：0
|
作者：
Schooler, N. R. [1 ]
Pikalov, A. [2 ]
Hsu, J. [2 ]
Cucchiaro, J. [2 ]
Goldman, R. [3 ]
Loebel, A. [2 ]
机构：
[1] Suny Downstate Med Ctr, Dept Psychiat & Behav Sci, Brooklyn, NY 11203 USA
[2] Sunov Pharmaceut Inc, Clin Dev & Med Affairs, Ft Lee, VA USA
[3] Sunov Pharmaceut Inc, Med Affairs, Marlborough, MA USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2014年 / 24卷
关键词：
D O I：
10.1016/S0924-977X(14)70893-4
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.3.d.060
引用
收藏
页码：S558 / S558
页数：1
相关论文
共 50 条
  • [1] Efficacy of Lurasidone in the Treatment of Schizophrenia with Prominent Negative Symptoms: A Post-hoc Analysis of Short-term Trials
    Schooler, Nina R.
    Pikalov, Andrei
    Hsu, Jay
    Cucchiaro, Josephine
    Goldman, Robert
    Loebel, Antony
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S513 - S514
  • [2] EFFICACY OF LURASIDONE IN THE TREATMENT OF SCHIZOPHRENIA WITH PROMINENT NEGATIVE SYMPTOMS: A POST-HOC ANALYSIS OF SHORT-TERM TRIALS
    Pikalov, Andrei
    Schooler, Nina
    Hsu, Jay
    Cucchiaro, Josephine
    Goldman, Robert
    Loebel, Antony
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S355 - S355
  • [3] Efficacy of lurasidone in the treatment of schizophrenia with prominent negative symptoms: A post-hoc analysis of short-term trials
    Schooler, N. R.
    Pikalov, A.
    Hsu, J.
    Cucchiaro, J.
    Goldman, R.
    Loebel, A.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 151 - 152
  • [4] Efficacy of lurasidone in the treatment of agitation: A post hoc analysis of five short-term studies in acutely ill patients with schizophrenia
    Allen, Michael H.
    Citrome, Leslie
    Pikalov, Andrei
    Hsu, Jay
    Loebel, Antony
    GENERAL HOSPITAL PSYCHIATRY, 2017, 47 : 75 - 82
  • [5] Efficacy of lurasidone in schizophrenia: pooled analysis of the five PANSS factors in short-term trials
    Werner, P.
    Cucchiaro, J.
    Silva, R.
    Pikalov, A.
    Mao, Y.
    Loebel, A.
    Marder, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S341 - S341
  • [6] Efficacy of lurasidone in schizophrenia : Factor analysis of pooled short-term trials
    Cucchiaro, J.
    Silva, R.
    Mao, Y.
    Pikalov, A.
    Loebel, A.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 125 - 125
  • [7] Efficacy of Karxt on Negative Symptoms in Acute Schizophrenia: A Post Hoc Analysis of Participants With Prominent Negative Symptoms
    Horan, William
    Claxton, Amy
    Targum, Steven D.
    Yohn, Samantha E.
    Kaul, Inder
    Sawchak, Sharon
    Miller, Andrew C.
    Paul, Steven M.
    Brannan, Stephen K.
    BIOLOGICAL PSYCHIATRY, 2024, 95 (10) : S268 - S269
  • [8] Short-term efficacy and safety of lurasidone in the treatment of schizophrenia
    Samalin, L.
    Ben Gharbia, M.
    Garnier, M.
    Llorca, P. -M.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2014, 40 (06): : 507 - 517
  • [9] Efficacy of Lurasidone in Patients With Schizophrenia With Prominent Positive Symptoms: A Pooled Analysis of Short-Term Placebo-Controlled Studies
    Potkin, Steven G.
    Tocco, Michael
    Mao, Yongcai
    Cucchiaro, Josephine
    Loebel, Antony
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 201 - 201
  • [10] Efficacy of lurasidone in patients with schizophrenia with prominent positive symptoms: a pooled analysis of short-term placebo-controlled studies
    Potkin, S.
    Tocco, M.
    Mao, Y.
    Cucchiaro, J.
    Loebel, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S562 - S563
12345